7 Hills Logo.png
7 Hills Pharma Highlights Cell Adhesion as Key to Improving Effectiveness of Covid-19 Vaccines and Immuno-Oncology Drugs At BIO Digital 2020 Online Conference
June 15, 2020 10:39 ET | 7 Hills Pharma
HOUSTON, June 15, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical-stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
7 Hills Logo.png
7 Hills Pharma to Deliver Video Presentation At BIO Digital 2020 June 8 – 12
June 04, 2020 12:58 ET | 7 Hills Pharma
Company is leveraging its integrin platform technology to improve effectiveness of immunotherapies, including Covid-19 vaccines HOUSTON, June 04, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a...
7 Hills Logo.png
7 Hills Pharma Announces Coronavirus Vaccine Program Targeting At-Risk Elderly
April 15, 2020 08:00 ET | 7 Hills Pharma
HOUSTON, April 15, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on development of drugs for the treatment and prevention of cancer and infectious diseases,...
dynavax_logo_notagline.jpg
Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine
March 02, 2020 08:00 ET | Dynavax Technologies Corporation
EMERYVILLE, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today...
Stellar Biotechnologies Files Provisional Application for Patent for KLH Adjuvant Innovations
February 06, 2013 10:36 ET | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Feb 6, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company has submitted a...
Stellar Biotechnologies Pioneers Aquaculture Milestone in KLH Protein Manufacturing
January 22, 2013 08:55 ET | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jan 22, 2013) -  Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company has successfully...
Stellar Biotechnologies to Present at Noble Financial Capital Markets Ninth Annual Equity Conference January 23, 2013
January 17, 2013 09:35 ET | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jan 18, 2013) -  Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of...
Stellar Biotechnologies to Present at Biotech Showcase(TM) in San Francisco on January 7th, 2013
January 02, 2013 10:15 ET | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jan 2, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable...
Stellar Biotechnologies to Present at LD Micro Conference in Los Angeles on December 5th, 2012
November 27, 2012 09:05 ET | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Nov 27, 2012) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable...
Stellar Biotechnologies to Present at SoCalBio Investor Conference in Los Angeles on November 7th, 2012
October 31, 2012 09:35 ET | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Oct 31, 2012) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable...